abstract |
The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, R 1 R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease. |